ダントロレンによるリアノジン受容体を分子標的とした新しい心不全・不整脈治療

悪性高熱症,カテコラミン誘発性多形性心室頻拍症(Catecholaminergic polymorphic ventricular tachycardia:CPVT)や心不全においては,リアノジン受容体(骨格筋型:RyR1,心筋型:RyR2)内のドメイン連関障害が,リアノジン受容体からのCa2+漏出の原因と考えられている.悪性高熱症の治療薬であるダントロレンは,RyR1に結合し,RyR1内のドメイン連関障害を是正することによってRyR1からのCa2+漏出を抑制する.同様に,イヌ心不全モデルやCPVT型knock-inマウスにおいてもダントンは,RyR2に結合し,RyR2からのCa2+漏出を抑制...

Full description

Saved in:
Bibliographic Details
Published in山口医学 Vol. 62; no. 1; pp. 15 - 19
Main Author 小林, 茂樹
Format Journal Article
LanguageJapanese
Published 山口大学医学会 01.02.2013
Subjects
Online AccessGet full text
ISSN0513-1731
1880-4462
DOI10.2342/ymj.62.15

Cover

Abstract 悪性高熱症,カテコラミン誘発性多形性心室頻拍症(Catecholaminergic polymorphic ventricular tachycardia:CPVT)や心不全においては,リアノジン受容体(骨格筋型:RyR1,心筋型:RyR2)内のドメイン連関障害が,リアノジン受容体からのCa2+漏出の原因と考えられている.悪性高熱症の治療薬であるダントロレンは,RyR1に結合し,RyR1内のドメイン連関障害を是正することによってRyR1からのCa2+漏出を抑制する.同様に,イヌ心不全モデルやCPVT型knock-inマウスにおいてもダントンは,RyR2に結合し,RyR2からのCa2+漏出を抑制し,心不全の進展やCPVTを抑制する.このように,ダントロレンはRyR2を分子標的とした新しい心不全・不整脈治療薬となることが期待される.
AbstractList 「和文抄録」悪性高熱症, カテコラミン誘発性多形性心室頻拍症(Catecholaminergic polymorphic ventricular tachycardia: CPVT)や心不全においては, リアノジン受容体(骨格筋型: RyR1, 心筋型: RyR2)内のドメイン連関障害が, リアノジン受容体からのCa2+漏出の原因と考えられている. 悪性高熱症の治療薬であるダントロレンは, RyR1に結合し, RyR1内のドメイン連関障害を是正することによってRyR1からのCa2+漏出を抑制する. 同様に, イヌ心不全モデルやCPVT型knock-inマウスにおいてもダントンは, RyR2に結合し, RyR2からのCa2+漏出を抑制し, 心不全の進展やCPVTを抑制する. このように, ダントロレンはRyR2を分子標的とした新しい心不全・不整脈治療薬となることが期待される. 「はじめに」心不全は心筋の収縮, 弛緩の障害を基盤とする症候群であり, その原因として心筋細胞内Ca2+調節の異常が重要である.
悪性高熱症,カテコラミン誘発性多形性心室頻拍症(Catecholaminergic polymorphic ventricular tachycardia:CPVT)や心不全においては,リアノジン受容体(骨格筋型:RyR1,心筋型:RyR2)内のドメイン連関障害が,リアノジン受容体からのCa2+漏出の原因と考えられている.悪性高熱症の治療薬であるダントロレンは,RyR1に結合し,RyR1内のドメイン連関障害を是正することによってRyR1からのCa2+漏出を抑制する.同様に,イヌ心不全モデルやCPVT型knock-inマウスにおいてもダントンは,RyR2に結合し,RyR2からのCa2+漏出を抑制し,心不全の進展やCPVTを抑制する.このように,ダントロレンはRyR2を分子標的とした新しい心不全・不整脈治療薬となることが期待される.
Author 小林, 茂樹
Author_xml – sequence: 1
  fullname: 小林, 茂樹
  organization: 山口大学大学院医学系研究科器官病態内科学(内科学第二)
BookMark eNo9kMFLG0EUxgdRMEYP_UM2nTezO7sLvZTQpoLgpZ6HyexsukuyKRt7yK3ZSSUgraXFBnsRPIVWRdRDJJT-MZON_hmOWnp43-_je_A9eGtoOetmCqFngGuEuuR5v5PWGKmBt4QqEATYcV1GllEFe0Ad8CmsorVeL8XYhYBCBXWN_mj0ldEjo8-MPn3wg9-mGJli3-hfpjgx-osppjYvD8bl-c38z3dTfCtHe-XZ18Xk6Pbn0AwmZjA2g-PFj4tHMyz_6vn0c_lpYvTMmsXh9d1wtLic3R4V62glFu2e2vjHKtp5_ept_Y2ztd3YrL_cclIIPOwo5kduLEFihmMSyZD6QVNEOMK-5wdKheA3ha9CwdwgalK7IHGTyJiF0nchAlpFjafejooSKdrdrJ1kiqfdD3lm7_JIeP1OSyacYKAcY2ZpQeyA9yAhhJQFJLRNL56a0t6uaCn-Pk86Iu9zke8msq24_ThnhMOjeP9j-U7kPBX0HghtoYw
ContentType Journal Article
Copyright 2013 山口大学医学会
Copyright_xml – notice: 2013 山口大学医学会
CorporateAuthor 山口大学大学院医学系研究科器官病態内科学(内科学第二
CorporateAuthor_xml – name: 山口大学大学院医学系研究科器官病態内科学(内科学第二
DOI 10.2342/ymj.62.15
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1880-4462
EndPage 19
ExternalDocumentID da5ymgci_2013_006201_002_0015_00191936829
article_ymj_62_1_62_15_article_char_ja
GroupedDBID 123
2WC
53G
ABJNI
ALMA_UNASSIGNED_HOLDINGS
CS3
JSF
KQ8
MOJWN
OK1
RJT
ID FETCH-LOGICAL-j1850-e67d4fc1c060f2dc9378bad0d07578ee917ba7e9a648db3d0d2fb2cf69c741d13
ISSN 0513-1731
IngestDate Thu Jul 10 16:14:33 EDT 2025
Wed Sep 03 06:30:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j1850-e67d4fc1c060f2dc9378bad0d07578ee917ba7e9a648db3d0d2fb2cf69c741d13
OpenAccessLink https://www.jstage.jst.go.jp/article/ymj/62/1/62_15/_article/-char/ja
PageCount 5
ParticipantIDs medicalonline_journals_da5ymgci_2013_006201_002_0015_00191936829
jstage_primary_article_ymj_62_1_62_15_article_char_ja
PublicationCentury 2000
PublicationDate 20130201
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: 20130201
  day: 01
PublicationDecade 2010
PublicationTitle 山口医学
PublicationTitleAlternate 山口医学
PublicationYear 2013
Publisher 山口大学医学会
Publisher_xml – name: 山口大学医学会
References 4) Kobayashi S, Yamamoto T, Parness J, Ikemoto N. Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptor. Biochem J 2004;380:561-569.
1) Yano M, Yamamoto T, Ikeda Y, Matsuzaki M. Mechanisms of Disease:ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 2006;3:43-52.
16) Kobayashi S, Yano M, Uchinoumi H, Suetomi T, Susa T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Yamamoto T, Matsuzaki M. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+)knock-in mouse model. Circ J 2010;74:2579-2584.
13) Kobayashi S, Yano M, Suetomi T, Ono M, Tateishi H, Mochizuki M, Xu X, Uchinoumi H, Okuda S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing inter-domain interactions within the ryanodine receptor. J Am Coll Cardiol 2009;53:1993-2005.
5) Oda T, Yano M, Yamamoto T, Tokuhisa T, Okuda S, Doi M, Ohkusa T, Ikeda Y, Kobayashi S, Ikemoto N, Matsuzaki M. Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 2005;111:3400-3410.
7) Yamamoto T, Yano M, Xu X, Uchinoumi H, Tateishi H, Mochizuki M, Oda T, Kobayashi S, Ikemoto N, Matsuzaki M. Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts. Circulation 2008;117:762-772.
15) Xu X, Yano M, Uchinoumi H, Hino A, Suetomi T, Ono M, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ikemoto N, Matsuzaki M. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. Biochem Biophys Res Commun 2010;394:660-666.
6) Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M. Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 2007;49:1722-32.
12) Kobayashi S, Bannister ML, Gangopadhyay JP, Hamada T, Parness J, Ikemoto N. Dantrolene stabilizes domain interactions within the ryanodine receptor. J Biol Chem 2005;280:6580-6587.
3) Yamamoto T, El-Hayek R, Ikemoto N. Postulated role of interdomain interaction within the ryanodine receptor in Ca2+ channel regulation. J Biol Chem 2000;275:11618-11625.
14) Uchinoumi H, Yano M, Suetomi T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. Circ Res 2010;106:1413-1424.
8) Tateishi H, Yano M, Mochizuki M, Suetomi T, Ono M, Xu X, Uchinoumi H, Okuda S, Oda T, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts. Cardiovasc Res 2009;81:536-45.
10) Liu Z, Wang R, Tian X, Zhong X, Gangopadhyay J, Cole R, Ikemoto N, Chen SR, Wagenknecht T. Dynamic, inter-subunit interactions between the N-terminal and central mutation regions of cardiac ryanodine receptor. J Cell Sci 2010 15;123:1775-1784.
17) McCauley MD, Wehrens XH. J. Targeting ryanodine receptors for anti-arrhythmic therapy. Acta Pharmacol Sin 2011;32:749-757.
9) Ono M, Yano M, Hino A, Suetomi T, Xu X, Susa T, Uchinoumi H, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M. Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure. Cardiovasc Res 2010;87(4):609-617.
11) Paul-Pletzer K, Yamamoto T, Bhat MB, Ma J, Ikemoto N, Jimenez LS, Morimoto H, Williams PG, Ma J, Parness J. Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J Biol Chem 2002;277:34918-34923.
2) Ikemoto N, Yamamoto T. Regulation of calcium release by interdomain interaction within ryanodine receptors. Front Biosci 2002;7:d671-683.
References_xml – reference: 15) Xu X, Yano M, Uchinoumi H, Hino A, Suetomi T, Ono M, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ikemoto N, Matsuzaki M. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. Biochem Biophys Res Commun 2010;394:660-666.
– reference: 10) Liu Z, Wang R, Tian X, Zhong X, Gangopadhyay J, Cole R, Ikemoto N, Chen SR, Wagenknecht T. Dynamic, inter-subunit interactions between the N-terminal and central mutation regions of cardiac ryanodine receptor. J Cell Sci 2010 15;123:1775-1784.
– reference: 1) Yano M, Yamamoto T, Ikeda Y, Matsuzaki M. Mechanisms of Disease:ryanodine receptor defects in heart failure and fatal arrhythmia. Nat Clin Pract Cardiovasc Med 2006;3:43-52.
– reference: 9) Ono M, Yano M, Hino A, Suetomi T, Xu X, Susa T, Uchinoumi H, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M. Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure. Cardiovasc Res 2010;87(4):609-617.
– reference: 8) Tateishi H, Yano M, Mochizuki M, Suetomi T, Ono M, Xu X, Uchinoumi H, Okuda S, Oda T, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M. Defective domain-domain interactions within the ryanodine receptor as a critical cause of diastolic Ca2+ leak in failing hearts. Cardiovasc Res 2009;81:536-45.
– reference: 2) Ikemoto N, Yamamoto T. Regulation of calcium release by interdomain interaction within ryanodine receptors. Front Biosci 2002;7:d671-683.
– reference: 13) Kobayashi S, Yano M, Suetomi T, Ono M, Tateishi H, Mochizuki M, Xu X, Uchinoumi H, Okuda S, Yamamoto T, Koseki N, Kyushiki H, Ikemoto N, Matsuzaki M. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing inter-domain interactions within the ryanodine receptor. J Am Coll Cardiol 2009;53:1993-2005.
– reference: 14) Uchinoumi H, Yano M, Suetomi T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M. Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor. Circ Res 2010;106:1413-1424.
– reference: 17) McCauley MD, Wehrens XH. J. Targeting ryanodine receptors for anti-arrhythmic therapy. Acta Pharmacol Sin 2011;32:749-757.
– reference: 16) Kobayashi S, Yano M, Uchinoumi H, Suetomi T, Susa T, Ono M, Xu X, Tateishi H, Oda T, Okuda S, Doi M, Yamamoto T, Matsuzaki M. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S/+)knock-in mouse model. Circ J 2010;74:2579-2584.
– reference: 3) Yamamoto T, El-Hayek R, Ikemoto N. Postulated role of interdomain interaction within the ryanodine receptor in Ca2+ channel regulation. J Biol Chem 2000;275:11618-11625.
– reference: 12) Kobayashi S, Bannister ML, Gangopadhyay JP, Hamada T, Parness J, Ikemoto N. Dantrolene stabilizes domain interactions within the ryanodine receptor. J Biol Chem 2005;280:6580-6587.
– reference: 5) Oda T, Yano M, Yamamoto T, Tokuhisa T, Okuda S, Doi M, Ohkusa T, Ikeda Y, Kobayashi S, Ikemoto N, Matsuzaki M. Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 2005;111:3400-3410.
– reference: 11) Paul-Pletzer K, Yamamoto T, Bhat MB, Ma J, Ikemoto N, Jimenez LS, Morimoto H, Williams PG, Ma J, Parness J. Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J Biol Chem 2002;277:34918-34923.
– reference: 6) Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, Matsuzaki M. Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 2007;49:1722-32.
– reference: 4) Kobayashi S, Yamamoto T, Parness J, Ikemoto N. Antibody probe study of Ca2+ channel regulation by interdomain interaction within the ryanodine receptor. Biochem J 2004;380:561-569.
– reference: 7) Yamamoto T, Yano M, Xu X, Uchinoumi H, Tateishi H, Mochizuki M, Oda T, Kobayashi S, Ikemoto N, Matsuzaki M. Identification of target domains of the cardiac ryanodine receptor to correct channel disorder in failing hearts. Circulation 2008;117:762-772.
SSID ssj0041831
ssib005880118
ssib000871986
ssib002484434
ssib002224191
ssib002220378
ssib005901909
Score 1.9307141
Snippet 悪性高熱症,カテコラミン誘発性多形性心室頻拍症(Catecholaminergic polymorphic ventricular tachycardia:CPVT)や心不全においては,リアノジン受容体(骨格筋...
「和文抄録」悪性高熱症, カテコラミン誘発性多形性心室頻拍症(Catecholaminergic polymorphic ventricular tachycardia: CPVT)や心不全においては, リアノジン受容体(骨格...
SourceID medicalonline
jstage
SourceType Publisher
StartPage 15
SubjectTerms ダントロレン
リアノジン受容体
心不全
心室頻拍
悪性高熱症
Title ダントロレンによるリアノジン受容体を分子標的とした新しい心不全・不整脈治療
URI https://www.jstage.jst.go.jp/article/ymj/62/1/62_15/_article/-char/ja
http://mol.medicalonline.jp/en/journal/download?GoodsID=da5ymgci/2013/006201/002&name=0015-0019j
Volume 62
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 山口医学, 2013/02/01, Vol.62(1), pp.15-19
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1880-4462
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0041831
  issn: 0513-1731
  databaseCode: KQ8
  dateStart: 20040101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1da9RAMNQKIoj4ifWLPriPqckm2ey-mVzvKEoFoYW-hVySEw_airYP9cm7VDkQtSha6ovgU1Eroj5Uivhjtnf1ZziTTc5c24daOPaG3dmZnf2cuduZ1bRrZmgmsV23dYcJS7eFEerCYonuxHaDuWAghA76Dk_eZhPT9s0ZZ2boyErp1tLiQn0serSvX8lhRhXyYFzRS_Y_RrZPFDIAhvGFFEYY0gONMalahFt4WUEBvlXk8BzwxgugMohjEs_PAFogA-AXyF6e49GCYDXP8XmJjkN4jQgXAa9KfEGqNvHHibByZEEzHE44y3CgCJrKiMeJAGSXCI9wu2gPzwEkqIAaIgtGfGN3EdZyiF_DliBTYDGe8XIKOtBCv1QEdAAfanGsiyIDWZrhuNgY9TZRoaZnxE38KBk9JWwlw88E8fq_aGa4BmIhkyq2EaZtxqiCnaDk9UX59xV862Lgrsr-DD2beG6f4d4mZPJVoBdL27ljYjDY_MxL1HEDu6cOBvnAecTonnWnDhfl95qrKeqg2X0AUsvGgLpLs80xRseKCgPxxPPZGgBOwGhgZokTFNno7Bc0weI4Sl3G8E2QW3fKCjusX14OsEcNqxQQjqJGKMqe0twuByB0QGCzpA2h57PAAHJKd7LhgMneuCz6SsUCQ6mu92UCXbEJlhOGxDgxq_7NVFFlSorh1CntZG7RjXpKstPaUDM8ox2bzO-snNXmZfpYpt9l2pHphkw_I9z6JNsd2X4m04-y_UGmL2R7E_K7L1e7X35u_3ot26-6nafdjZXe-trOu2XZWpetVdl633v7NQOWu7_T7c3n3SfrMt0CoPfmx5_lTu_b1s5a-5w2XatOVSb0_JkTvQnKsqEnzIWNMTIjgxkNGkdgMPB6GBuxgW9NJIkw3XroJiJkNo_rFhTQRp1GDSYiMAdi0zqvDc_NzyUXtFHHTSxOk7BuuradMC4SbkVOJBLbiSObhiOao7ouuK9i2QQHmw0j2o2Bng7yTfBhEIfO0uzd6F6ASydAj2zDhC-Kd2UdTARYiIxTcfGQrC9px_-tysva8MKDxeQK2AEL9avZ1PwLAwXmig
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E3%83%80%E3%83%B3%E3%83%88%E3%83%AD%E3%83%AC%E3%83%B3%E3%81%AB%E3%82%88%E3%82%8B%E3%83%AA%E3%82%A2%E3%83%8E%E3%82%B8%E3%83%B3%E5%8F%97%E5%AE%B9%E4%BD%93%E3%82%92%E5%88%86%E5%AD%90%E6%A8%99%E7%9A%84%E3%81%A8%E3%81%97%E3%81%9F%E6%96%B0%E3%81%97%E3%81%84%E5%BF%83%E4%B8%8D%E5%85%A8%E3%83%BB%E4%B8%8D%E6%95%B4%E8%84%88%E6%B2%BB%E7%99%82&rft.jtitle=%E5%B1%B1%E5%8F%A3%E5%8C%BB%E5%AD%A6&rft.au=%E5%B0%8F%E6%9E%97%2C+%E8%8C%82%E6%A8%B9&rft.date=2013-02-01&rft.pub=%E5%B1%B1%E5%8F%A3%E5%A4%A7%E5%AD%A6%E5%8C%BB%E5%AD%A6%E4%BC%9A&rft.issn=0513-1731&rft.eissn=1880-4462&rft.volume=62&rft.issue=1&rft.spage=15&rft.epage=19&rft_id=info:doi/10.2342%2Fymj.62.15&rft.externalDocID=article_ymj_62_1_62_15_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0513-1731&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0513-1731&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0513-1731&client=summon